Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer
Open Access
- 1 November 1999
- journal article
- case report
- Published by Elsevier in Annals of Oncology
- Vol. 10 (11) , 1381-1383
- https://doi.org/10.1023/a:1008362620308
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Biological and Clinical Significance of Cathepsin D in Breast Cancer MetastasisThe International Journal of Cell Cloning, 1996
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.Journal of Clinical Oncology, 1995
- Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced CancerJNCI Journal of the National Cancer Institute, 1993
- Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in miceInternational Journal of Immunopharmacology, 1989